{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:37:47Z","timestamp":1785796667123,"version":"3.56.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":292,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bbagen.2021.129963","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:09:21Z","timestamp":1625789361000},"page":"129963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Antitumoral synergism between a copper(II) complex and cisplatin improves in vitro and in vivo anticancer activity against melanoma, lung and breast cancer cells"],"prefix":"10.1016","volume":"1865","author":[{"given":"D.","family":"Mariani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Ghasemishahrestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pezzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Costa-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tanuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Kanashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"A.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.D.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2021.129963_bb0005","first-page":"749","article-title":"Cancer: 100 different diseases","volume":"66","author":"Moore","year":"1966","journal-title":"Am. J. Nurs."},{"key":"10.1016\/j.bbagen.2021.129963_bb0010","author":"World Health Organization"},{"key":"10.1016\/j.bbagen.2021.129963_bb0015","series-title":"Pediatr. Oncol","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-3-319-30789-3_15","article-title":"Chemotherapy","author":"Nicolaides","year":"2017"},{"key":"10.1016\/j.bbagen.2021.129963_bb0020","series-title":"Fundam. Pharm. Nanosci","first-page":"401","article-title":"Cancer chemotherapy","author":"Nakamura","year":"2013"},{"key":"10.1016\/j.bbagen.2021.129963_bb0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: a new class of potent antitumour agents","volume":"222","author":"ROSENBERG","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2021.129963_bb0030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5935\/0101-2800.20130052","article-title":"Acute nephrotoxicity of cisplatin: molecular mechanisms","volume":"35","author":"Ibert","year":"2013","journal-title":"J. Bras. Nefrol."},{"key":"10.1016\/j.bbagen.2021.129963_bb0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MAJ.0b013e31812dfe1e","article-title":"Cisplatin nephrotoxicity: a review","volume":"334","author":"Yao","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.bbagen.2021.129963_bb0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cbpa.2007.11.013","article-title":"New trends for metal complexes with anticancer activity","volume":"12","author":"Bruijnincx","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bbagen.2021.129963_bb0045","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2174\/138161209787582183","article-title":"Metal complexes, their cellular targets and potential for cancer therapy","volume":"15","author":"Chen","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbagen.2021.129963_bb0050","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2174\/138161210791209009","article-title":"Novel metals and metal complexes as platforms for cancer therapy","volume":"16","author":"Frezza","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbagen.2021.129963_bb0055","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2147\/DDDT.S119488","article-title":"Metal complexes in cancer therapy &ndash; an update from drug design perspective","volume":"11","author":"Ndagi","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.bbagen.2021.129963_bb0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/0929867323666160824162546","article-title":"Vanadium, ruthenium and copper compounds: a new class of nonplatinum metallodrugs with anticancer activity","volume":"24","author":"Leon","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0065","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1021\/acs.chemrev.8b00209","article-title":"Stimuli-responsive therapeutic metallodrugs","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbagen.2021.129963_bb0070","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4155\/fmc-2017-0317","article-title":"Anticancer metallodrugs: where is the next cisplatin?","volume":"10","author":"Hanif","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0075","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00057-15","article-title":"Reduction of Toxoplasma gondii development due to inhibition of parasite antioxidant enzymes by a dinuclear iron(III) compound","volume":"59","author":"Portes","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2021.129963_bb0080","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jinorgbio.2010.07.011","article-title":"Synthesis, characterization and antibacterial activity of FeIII, CoII, CuII and ZnII complexes probed by transmission electron microscopy","volume":"104","author":"Fernandes","year":"2010","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ica.2014.02.040","article-title":"Synthesis, characterization, antibacterial and antitumoral activities of mononuclear zinc complexes containing tridentate amine based ligands with N3 or N2O donor groups","volume":"416","author":"Fernandes","year":"2014","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.bbagen.2021.129963_bb0090","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbagen.2021.129963_bb0095","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1039\/C6CS00860G","article-title":"Using titanium complexes to defeat cancer: the view from the shoulders of titans","volume":"46","author":"Cini","year":"2017","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bbagen.2021.129963_bb0100","series-title":"Met. Dev. Action Anticancer Agents, De Gruyter","first-page":"251","article-title":"9. Health benefits of vanadium and its potential as an anticancer agent","author":"Crans","year":"2018"},{"key":"10.1016\/j.bbagen.2021.129963_bb0105","series-title":"Met. Dev. Action Anticancer Agents, De Gruyter","first-page":"469","article-title":"16. Copper complexes in cancer therapy","author":"Denoyer","year":"2018"},{"key":"10.1016\/j.bbagen.2021.129963_bb0110","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1039\/C5NJ01449B","article-title":"Recent advances in iron complexes as potential anticancer agents","volume":"40","author":"Wani","year":"2016","journal-title":"New J. Chem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0115","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/BF00390468","article-title":"Ferricenium complexes: a new type of water-soluble antitumor agent","volume":"108","author":"Kopf-Maier","year":"1984","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbagen.2021.129963_bb0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molstruc.2016.02.045","article-title":"Synthesis, structural characterization, modal membrane interaction and anti-tumor cell line studies of nitrophenyl ferrocenes","volume":"1113","author":"Altaf","year":"2016","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbagen.2021.129963_bb0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ica.2017.04.034","article-title":"Ferrocene-based Schiff bases copper (II) complexes: synthesis, characterization, biological and electrochemical analysis","volume":"463","author":"Shabbir","year":"2017","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.bbagen.2021.129963_bb0130","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1039\/C8CC03308K","article-title":"Assessment of the antitumor activity of a cyclopalladated ferrocene compound assisted by a dual-targeting drug delivery system","volume":"54","author":"Gong","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bbagen.2021.129963_bb0135","doi-asserted-by":"crossref","DOI":"10.1007\/BF00390468","article-title":"Ferricenium complexes: a new type of water-soluble antitumor agent","author":"K\u00f6pf-Maier","year":"1984","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbagen.2021.129963_bb0145","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv467","article-title":"Intercalation processes of copper complexes in DNA","author":"Galindo-Murillo","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbagen.2021.129963_bb0150","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.2174\/092986710793213751","article-title":"Copper compounds in cancer chemotherapy","volume":"17","author":"Ruiz-Azuara","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10534-007-9089-4","article-title":"Casiopeina III-ia induces apoptosis in HCT-15 cells in vitro through caspase-dependent mechanisms and has antitumor effect in vivo","volume":"21","author":"Carvallo-Chaigneau","year":"2008","journal-title":"BioMetals"},{"key":"10.1016\/j.bbagen.2021.129963_bb0160","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/aoc.3309","article-title":"Synthesis, characterization and assessment of the cytotoxic activity of Cu(II), Fe(III) and Mn(III) complexes of camphoric acid-derived salen ligands","volume":"29","author":"Murtinho","year":"2015","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/187152009787313837","article-title":"Copper complexes as anticancer agents","volume":"9","author":"Marzano","year":"2009","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0170","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1089\/ars.2010.3663","article-title":"Anticancer activity of metal complexes: involvement of redox processes","volume":"15","author":"Jungwirth","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbagen.2021.129963_bb0175","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/ars.2009.2876","article-title":"Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential","volume":"13","author":"Batini\u0107-Haberle","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbagen.2021.129963_bb0180","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejmech.2017.01.045","article-title":"Synergistic effects between a copper-based metal Casiope\u00edna III-ia and cisplatin","volume":"129","author":"Davila-Manzanilla","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2014.12.005","article-title":"Iron, copper, and manganese complexes with in vitro superoxide dismutase and \/ or catalase activities that keep Saccharomyces cerevisiae cells alive under severe oxidative stress","volume":"80","author":"Ribeiro","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbagen.2021.129963_bb0190","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/BCJ20160480","article-title":"Metal-based superoxide dismutase and catalase mimics reduce oxidative stress biomarkers and extend life span of Saccharomyces cerevisiae","volume":"474","author":"Ribeiro","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbagen.2021.129963_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2005.03.045","article-title":"Coordination chemistry of the new ligand 1-(bis-pyridin-2-ylmethyl-amino)- 3-chloropropan-2-ol (HPClNOL) with copper(II). X-ray crystal structure, spectroscopic and electrochemical properties of the complex [Cu(HPClNOL)(CH 3CN)](ClO4)2","author":"Horn","year":"2005","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bbagen.2021.129963_bb0200","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1021\/ic901904b","article-title":"An iron-based cytosolic catalase and superoxide dismutase mimic complex","volume":"49","author":"Horn","year":"2010","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0205","series-title":"Separation of Blood Leucocytes, Granulocytes and Lymphocytes","author":"Boyum","year":"1974"},{"key":"10.1016\/j.bbagen.2021.129963_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","author":"Denizot","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bbagen.2021.129963_bb0215","doi-asserted-by":"crossref","DOI":"10.1039\/c0md00266f","article-title":"Water-soluble bis(1,10-phenanthroline) octanedioate Cu 2+ and Mn 2+ complexes with unprecedented nano and picomolar in vitro cytotoxicity: promising leads for chemotherapeutic drug development","volume":"2","author":"Kellett","year":"2011","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bbagen.2021.129963_bb0220","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0304-4165(03)00003-5","article-title":"Targets of oxidative stress in yeast sod mutants","volume":"1620","author":"Pereira","year":"2003","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"key":"10.1016\/j.bbagen.2021.129963_bb0225","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1073\/pnas.88.9.3671","article-title":"Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1","volume":"88","author":"Smiley","year":"1991","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbagen.2021.129963_bb0230","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/137.2.122","article-title":"A method for testing for synergy with any number of agents","volume":"137","author":"Berenbaum","year":"1978","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbagen.2021.129963_bb0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/jac\/19.1.119","article-title":"Chequerboard titrations: the influence of the composition of serial dilutions of antibiotics on the fractional inhibitory concentration index and fractional bactericidal concentration index","volume":"19","author":"Horrevorts","year":"1987","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbagen.2021.129963_bb0240","doi-asserted-by":"crossref","first-page":"L799","DOI":"10.1152\/ajplung.2000.279.5.L799","article-title":"Synergistic and additive killing by antimicrobial factors found in human airway surface liquid","volume":"279","author":"Singh","year":"2000","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"10.1016\/j.bbagen.2021.129963_bb0245","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/AAC.00999-09","article-title":"Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against aspergillus fumi","volume":"54","author":"Meletiadis","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2021.129963_bb0250","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1186\/s12885-017-3677-7","article-title":"A systematic investigation of the maximum tolerated dose of cytotoxic chemotherapy with and without supportive care in mice","volume":"17","author":"Aston","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbagen.2021.129963_bb0255","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejmech.2016.07.018","article-title":"In vitro and in vivo studies of the antineoplastic activity of copper (II) compounds against human leukemia THP-1 and murine melanoma B16-F10 cell lines","volume":"123","author":"Borges","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0260","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ejic.201600908","article-title":"Redox-active metal complexes for anticancer therapy","volume":"2017","author":"Zhang","year":"2017","journal-title":"Eur. J. Inorg. Chem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0265","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jorganchem.2017.03.038","article-title":"Advances in the design of organometallic anticancer complexes","volume":"839","author":"Zhang","year":"2017","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2013.04.014","article-title":"Transplatin enhances effect of cisplatin on both single DNA molecules and live tumor cells","author":"Liu","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2021.129963_bb0285","doi-asserted-by":"crossref","DOI":"10.1039\/D0RA00166J","article-title":"Iron and copper complexes with antioxidant activity as inhibitors of the metastatic potential of glioma cells","author":"Guerreiro","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbagen.2021.129963_bb0290","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.ica.2006.04.007","article-title":"Synthesis, crystal structure, nuclease and in vitro antitumor activities of a new mononuclear copper(II) complex containing a tripodal N3O ligand","volume":"359","author":"Fernandes","year":"2006","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.bbagen.2021.129963_bb0295","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1080\/07391102.2020.1733663","article-title":"Synthesis and characterization of copper\u2013based anticancer compound; in vitro interaction studies with DNA\/HSA, SOD mimetic, cytotoxic activity and molecular docking investigation","volume":"39","author":"Al-Asbahy","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbagen.2021.129963_bb0300","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11243-018-0234-4","article-title":"Enantiomeric pairs of copper(II) polypyridyl-alanine complex salts: anticancer studies","volume":"43","author":"Ng","year":"2018","journal-title":"Transit. Met. Chem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0305","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/scrt139","article-title":"The multi-differentiation potential of peripheral blood mononuclear cells","volume":"3","author":"Zhang","year":"2012","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.bbagen.2021.129963_bb0310","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.msec.2016.05.120","article-title":"Antioxidant, DNA interaction, VEGFR2 kinase, topoisomerase I and in vitro cytotoxic activities of heteroleptic copper(II) complexes of tetrazolo[1,5-a]pyrimidines and diimines","volume":"68","author":"Haleel","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.bbagen.2021.129963_bb0315","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/10715762.2015.1133907","article-title":"Histidine availability is decisive in ROS-mediated cytotoxicity of copper complexes of A\u03b21\u201316 peptide","volume":"50","author":"Ginotra","year":"2016","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bbagen.2021.129963_bb0320","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF02870838","article-title":"Activation of dioxygen molecules on dinuclear metal centers","volume":"111","author":"Moro-Oka","year":"1999","journal-title":"Proc. Indian Acad. Sci. Chem. Sci."},{"key":"10.1016\/j.bbagen.2021.129963_bb0325","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/med.20174","article-title":"Copper in diseases and treatments, and copper-based anticancer strategies","volume":"30","author":"Tisato","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbagen.2021.129963_bb0330","series-title":"Adv. Inorg. Chem","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0898-8838(09)00201-3","article-title":"Controlling platinum, ruthenium, and osmium reactivity for anticancer drug design","author":"Bruijnincx","year":"2009"},{"key":"10.1016\/j.bbagen.2021.129963_bb0335","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.drudis.2009.09.003","article-title":"Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs","volume":"14","author":"van Rijt","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbagen.2021.129963_bb0340","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF02703829","article-title":"Copper complexes as chemical nucleases","volume":"114","author":"Chakravarty","year":"2002","journal-title":"J. Chem. Sci."},{"key":"10.1016\/j.bbagen.2021.129963_bb0345","article-title":"Copper complexes based on chiral Schiff-base ligands: DNA\/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis","author":"Zhou","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0350","doi-asserted-by":"crossref","first-page":"S668","DOI":"10.1016\/j.arabjc.2011.07.029","article-title":"Synthesis, characterization, anti-microbial, DNA binding and cleavage studies of Schiff base metal complexes","volume":"9","author":"Jayaseelan","year":"2016","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bbagen.2021.129963_bb0355","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3390\/ijms17070997","article-title":"Brusatol enhances the radiosensitivity of A549 cells by promoting ROS production and enhancing DNA damage","volume":"17","author":"Sun","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbagen.2021.129963_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/6653790","article-title":"H2O2-driven anticancer activity of Mn porphyrins and the underlying molecular pathways","volume":"2021","author":"Batinic-Haberle","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.bbagen.2021.129963_bb0365","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.948.65.3","article-title":"Controlling tumor growth by modulating endogenous production of reactive oxygen species","volume":"65","author":"Laurent","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagen.2021.129963_bb0370","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd2683","article-title":"Mechanisms of drug combinations: interaction and network perspectives","volume":"8","author":"Jia","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbagen.2021.129963_bb0375","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50036","article-title":"A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity","volume":"8","author":"Palmer","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.bbagen.2021.129963_bb0380","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/JEP.S177032","article-title":"Bioactive constituents isolated from Atractylodes lancea (Thunb.) DC. rhizome exhibit synergistic effect against cholangiocarcinoma cell","volume":"10","author":"Martviset","year":"2018","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.bbagen.2021.129963_bb0385","doi-asserted-by":"crossref","first-page":"111166","DOI":"10.1016\/j.jinorgbio.2020.111166","article-title":"In vitro and in vivo anti-proliferative activity and ultrastructure investigations of a copper(II) complex toward human lung cancer cell NCI-H460","volume":"210","author":"Maciel","year":"2020","journal-title":"J. Inorg. Biochem."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416521001227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416521001227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:10:43Z","timestamp":1759637443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416521001227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":74,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0304416521001227"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2021.129963","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antitumoral synergism between a copper(II) complex and cisplatin improves in vitro and in vivo anticancer activity against melanoma, lung and breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2021.129963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"129963"}}